outcome in primary gastric DLBC lymphoma We read with interest the original article published in the Annals of Oncology by Binn et al. [1], addressing the role of surgery plus chemotherapy in the management of diffuse large B-cell gastric lymphoma. We would like to make a correction in this regard. The authors stated that their results support the prognostic value of the International Prognostic Index (IPI) in predicting survival out-come in localized gastric lymphoma, and in the next sentence they indicate that these results are in agreement with ours, published in 1999, in one of the largest published series about this disease [2]. In fact, according to our paper, the IPI failed to classify patients into prognostically meaningful risk str...
Towards new prognostic factors in diffuse large cell non-Hodgkin's lymphoma Non-Hodgkin's ...
This study attempted to evaluate the usefulness of the International Prognostic Index (IPI) as a pro...
textabstractBackground: The aim of this study was to validate the Follicular Lymphoma International ...
BACKGROUND: The definition of prognostic parameters in early stages of gastric lymphoma is still con...
We have previously reported on the efficacy of a modified International Prognostic Index (MIPI) in p...
BACKGROUND: Improved treatment have modified survival outcome in patients with diffuse large B-cell ...
is also used in follicular lymphoma (FL) and other indolent lymphomas. Two new prognostic indexes ha...
BACKGROUND: Improved treatment have modified survival outcome in patients with diffuse large B-cell ...
Introduction: Whilst the addition of rituximab, a humanized monoclonal antibody to standard CHOP che...
Primary gastrointestinal (GIT) lymphoma constitutes only 5 – 10 % of all gastrointestinal tumours. T...
Abstract Currently, the International Prognostic Index (IPI) is the most used and reported model for...
Background: Different prognostic scores have been proposed to predict the outcome of follicular lymp...
Stage-modified international prognostic index effectively predicts clinical outcome of localized pri...
Background and Aims: The results of class prediction and the determination of prognostic markers in ...
The international prognostic index (IPI) and similar models form the cornerstone of clinical assessm...
Towards new prognostic factors in diffuse large cell non-Hodgkin's lymphoma Non-Hodgkin's ...
This study attempted to evaluate the usefulness of the International Prognostic Index (IPI) as a pro...
textabstractBackground: The aim of this study was to validate the Follicular Lymphoma International ...
BACKGROUND: The definition of prognostic parameters in early stages of gastric lymphoma is still con...
We have previously reported on the efficacy of a modified International Prognostic Index (MIPI) in p...
BACKGROUND: Improved treatment have modified survival outcome in patients with diffuse large B-cell ...
is also used in follicular lymphoma (FL) and other indolent lymphomas. Two new prognostic indexes ha...
BACKGROUND: Improved treatment have modified survival outcome in patients with diffuse large B-cell ...
Introduction: Whilst the addition of rituximab, a humanized monoclonal antibody to standard CHOP che...
Primary gastrointestinal (GIT) lymphoma constitutes only 5 – 10 % of all gastrointestinal tumours. T...
Abstract Currently, the International Prognostic Index (IPI) is the most used and reported model for...
Background: Different prognostic scores have been proposed to predict the outcome of follicular lymp...
Stage-modified international prognostic index effectively predicts clinical outcome of localized pri...
Background and Aims: The results of class prediction and the determination of prognostic markers in ...
The international prognostic index (IPI) and similar models form the cornerstone of clinical assessm...
Towards new prognostic factors in diffuse large cell non-Hodgkin's lymphoma Non-Hodgkin's ...
This study attempted to evaluate the usefulness of the International Prognostic Index (IPI) as a pro...
textabstractBackground: The aim of this study was to validate the Follicular Lymphoma International ...